- Home
- EQS vs CRIS Comparison
EQS vs CRIS Comparison
Compare EQS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQS
- CRIS
- Stock Information
- Founded
- EQS 1991
- CRIS 2000
- Country
- EQS United States
- CRIS United States
- Employees
- EQS N/A
- CRIS N/A
- Industry
- EQS Finance Companies
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EQS Finance
- CRIS Health Care
- Exchange
- EQS Nasdaq
- CRIS Nasdaq
- Market Cap
- EQS 13.9M
- CRIS 13.5M
- IPO Year
- EQS N/A
- CRIS 2000
- Fundamental
- Price
- EQS $0.85
- CRIS $2.02
- Analyst Decision
- EQS
- CRIS Strong Buy
- Analyst Count
- EQS 0
- CRIS 3
- Target Price
- EQS N/A
- CRIS $21.00
- AVG Volume (30 Days)
- EQS 5.3K
- CRIS 106.4K
- Earning Date
- EQS 01-01-0001
- CRIS 05-06-2025
- Dividend Yield
- EQS N/A
- CRIS N/A
- EPS Growth
- EQS N/A
- CRIS N/A
- EPS
- EQS N/A
- CRIS N/A
- Revenue
- EQS $1,274,000.00
- CRIS $11,202,000.00
- Revenue This Year
- EQS N/A
- CRIS $2.62
- Revenue Next Year
- EQS N/A
- CRIS $9.84
- P/E Ratio
- EQS N/A
- CRIS N/A
- Revenue Growth
- EQS 411.65
- CRIS 14.17
- 52 Week Low
- EQS $0.87
- CRIS $1.02
- 52 Week High
- EQS $1.53
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- EQS 37.58
- CRIS 52.24
- Support Level
- EQS $0.74
- CRIS $1.06
- Resistance Level
- EQS $1.01
- CRIS $2.45
- Average True Range (ATR)
- EQS 0.05
- CRIS 0.30
- MACD
- EQS -0.01
- CRIS 0.02
- Stochastic Oscillator
- EQS 33.94
- CRIS 36.19
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.